✦ LIBER ✦

Phase II trial of irinotecan (CPT-11) plus raltitrexed (ZD) in patients with previously untreated, advanced colorectal cancer (ACC)

✍ Scribed by Aparicio, J.; Vicent, J.; Maestu, I.; Galán, A.; Bosch, C.; Busquier, I.; Garcerá, S.; Llorca, C.; Campos, J.; Balcells, M.

Book ID: 122755296
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 160 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(01)81608-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase II study of CPT-11 plus

Randomized phase II study of CPT-11 plus mitomycin C versus oxaliplatin plus mitomycin C in previously treated patients with advanced colorectal cancer (ACC)

✍ H. Ulrich-Pur; S. Brugger; G.V. Kornek; W. Fiebiger; K. Haider; W. Kwasny; D. De 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 232 KB

A multicenter, Phase II trial of weekly

A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma

✍ Mace L. Rothenberg; John V. Cox; Russell F. DeVore; John D. Hainsworth; Richard 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 2 views

## Background: This multicenter, phase ii trial was performed to evaluate the antitumor activity and toxicity of irinotecan (cpt-11) in patients with metastatic colorectal carcinoma that had recurred or progressed after 5-fluorouracil (5-fu)-based chemotherapy. ## Methods: Cpt-11 was given as a 9

Phase II study of weekly irinotecan (CPT

Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer

✍ J. Cassinello; P. López-Alvarez; A. Martínez-Guisado; M. Valladares; G. Huidobro 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 106 KB

Oxaliplatin plus raltitrexed in patients

Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma : Results of a Phase I–II trial

✍ Werner Scheithauer; Gabriela V. Kornek; Herbert Ulrich-Pur; Melitta Penz; Markus 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

A phase II study of capecitabine, irinot

A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer

✍ Daniel J. Renouf; Stephen Welch; Malcolm J. Moore; Monika K. Krzyzanowska; Jenni 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 294 KB

A randomised phase II multicentre trial

A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer

✍ Schoemaker, N E; Kuppens, I E L M; Moiseyenko, V; Glimelius, B; Kjaer, M; Starkh 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB